Largest health care companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
UnitedHealth Group leads the 170 health care companies ranked by total liabilities, at SGD 268.1B, ahead of CVS Health (SGD 229.7B) and AbbVie (SGD 176.9B). Figures as of 19 Nov 2026, 14:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupSGD 268.1B
- Median
- SGD 3.9B
- Combined market value
- SGD 11.73T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IDEXX LaboratoriesIDXX · Health Care | SGD 2.3B | SGD 71B | SGD 900.64 | 1.19% up | 1% up | ||
| 102 | InsuletPODD · Health Care | SGD 2.2B | SGD 12.5B | SGD 180.50 | 3.69% down | 55% down | ||
| 103 | Ascendis PharmaASND · Health Care | SGD 2.1B | SGD 22.9B | SGD 348.58 | 0.32% down | 29% up | ||
| 104 | Hims & Hers HealthHIMS · Health Care | SGD 2.1B | SGD 5.2B | SGD 21.99 | 2.85% down | 49% down | ||
| 105 | HaemoneticsHAE · Health Care | SGD 2.1B | SGD 7.2B | SGD 158.42 | 1.60% up | 64% up | ||
| 106 | InsmedINSM · Health Care | SGD 2B | SGD 33.9B | SGD 154.48 | 1.69% down | 40% down | ||
| 107 | Medpace HoldingsMEDP · Health Care | SGD 2B | SGD 23.3B | SGD 834.11 | 0.95% down | 10% up | ||
| 108 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.9B | SGD 15.3B | SGD 79.21 | 4.99% up | 17% up | ||
| 109 | LivaNovaLIVN · Health Care | SGD 1.8B | SGD 6.7B | SGD 121.90 | 2.85% up | 77% up | ||
| 110 | Neurocrine BiosciencesNBIX · Health Care | SGD 1.8B | SGD 21.3B | SGD 210.00 | 1.84% down | 17% up | ||
| 111 | argenxARGX · Health Care | SGD 1.8B | SGD 76.3B | SGD 1,213.69 | 0.66% down | 2% up | ||
| 112 | HealthEquityHQY · Health Care | SGD 1.6B | SGD 10.4B | SGD 125.48 | 4.45% down | 3% down | ||
| 113 | MSA SafetyMSA · Health Care | SGD 1.5B | SGD 8.8B | SGD 228.81 | 2.67% up | 16% up | ||
| 114 | Lantheus HoldingsLNTH · Health Care | SGD 1.5B | SGD 8.6B | SGD 131.52 | 0.20% up | 90% up | ||
| 115 | Merit Medical SystemsMMSI · Health Care | SGD 1.4B | SGD 6.6B | SGD 110.80 | 1.70% up | 1% up | ||
| 116 | West Pharmaceutical ServicesWST · Health Care | SGD 1.4B | SGD 36.3B | SGD 520.96 | 2.44% down | 57% up | ||
| 117 | MiniMed GroupMMED · Health Care | SGD 1.3B | SGD 6.2B | SGD 21.91 | 4.44% down | 8% down | ||
| 118 | ImmunityBioIBRX · Health Care | SGD 1.3B | SGD 9.2B | SGD 8.64 | 7.03% up | 232% up | ||
| 119 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.9B | SGD 55.59 | 0.28% up | 13% up | ||
| 120 | RepligenRGEN · Health Care | SGD 1.1B | SGD 14.2B | SGD 222.65 | 6.47% up | 12% up | ||
| 121 | United TherapeuticsUTHR · Health Care | SGD 1B | SGD 31.7B | SGD 744.45 | 1.16% down | 22% up | ||
| 122 | Legend BiotechLEGN · Health Care | SGD 943.4M | SGD 4.1B | SGD 20.95 | 0.87% up | 41% down | ||
| 123 | Globus MedicalGMED · Health Care | SGD 940.7M | SGD 12B | SGD 90.94 | 0.77% up | 14% down | ||
| 124 | Revolution MedicinesRVMD · Health Care | SGD 932.5M | SGD 44.6B | SGD 206.08 | 1.76% down | 129% up | ||
| 125 | NateraNTRA · Health Care | SGD 884.5M | SGD 54.1B | SGD 373.30 | 0.71% up | 28% up | ||
| 126 | ExelixisEXEL · Health Care | SGD 880.8M | SGD 21.5B | SGD 88.06 | 0.31% down | 63% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | SGD 880.6M | SGD 6.8B | SGD 17.76 | 2.82% down | 123% up | ||
| 128 | AlkermesALKS · Health Care | SGD 861M | SGD 10.2B | SGD 60.41 | 3.08% up | 66% up | ||
| 129 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 847M | SGD 11.9B | SGD 513.30 | 5.67% down | 27% down | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | SGD 775.6M | SGD 9.1B | SGD 172.79 | 1.43% down | 6% down | ||
| 131 | ChemedCHE · Health Care | SGD 720.5M | SGD 9.1B | SGD 704.97 | 0.01% down | 27% up | ||
| 132 | Caris Life SciencesCAI · Health Care | SGD 707.1M | SGD 7.2B | SGD 25.14 | 2.21% down | 19% down | ||
| 133 | Ligand PharmaceuticalsLGND · Health Care | SGD 700.7M | SGD 7.7B | SGD 385.17 | 1.67% up | 50% up | ||
| 134 | Mirum PharmaceuticalsMIRM · Health Care | SGD 681M | SGD 7.8B | SGD 119.26 | 0.59% up | 34% up | ||
| 135 | Travere TherapeuticsTVTX · Health Care | SGD 632.3M | SGD 6.2B | SGD 64.78 | 1.68% down | 45% up | ||
| 136 | Bio-TechneTECH · Health Care | SGD 617M | SGD 14.7B | SGD 93.81 | 0.17% up | 24% up | ||
| 137 | Roivant SciencesROIV · Health Care | SGD 536.8M | SGD 36.2B | SGD 49.94 | 0.05% up | 91% up | ||
| 138 | TG TherapeuticsTGTX · Health Care | SGD 535.4M | SGD 12.9B | SGD 85.26 | 5.44% up | 117% up | ||
| 139 | PenumbraPEN · Health Care | SGD 514.4M | SGD 16.3B | SGD 413.40 | 0.47% up | 15% up | ||
| 140 | GRAILGRAL · Health Care | SGD 443.8M | SGD 5.9B | SGD 131.65 | 3.57% down | 19% up | ||
| 141 | CRISPR TherapeuticsCRSP · Health Care | SGD 442.8M | SGD 5B | SGD 51.82 | 0.10% up | 18% down | ||
| 142 | VaxcytePCVX · Health Care | SGD 409M | SGD 11.9B | SGD 75.46 | 1.48% down | 23% up | ||
| 143 | Cogent BiosciencesCOGT · Health Care | SGD 388.4M | SGD 6.2B | SGD 35.86 | 0.14% down | 20% down | ||
| 144 | Adaptive BiotechnologiesADPT · Health Care | SGD 371M | SGD 5.9B | SGD 36.70 | 0.11% down | 74% up | ||
| 145 | 10x GenomicsTXG · Health Care | SGD 316M | SGD 9.7B | SGD 73.59 | 1.37% up | 247% up | ||
| 146 | GlaukosGKOS · Health Care | SGD 306M | SGD 17.8B | SGD 300.55 | 4.18% down | 145% up | ||
| 147 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 271M | SGD 10.6B | SGD 153.50 | 2.08% up | 18% up | ||
| 148 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 252.8M | SGD 9.6B | SGD 122.56 | 0.06% down | 129% up | ||
| 149 | Kodiak SciencesKOD · Health Care | SGD 250.3M | SGD 8.2B | SGD 126.12 | 1.04% up | 399% up | ||
| 150 | Corcept TherapeuticsCORT · Health Care | SGD 243.5M | SGD 9.6B | SGD 87.41 | 3.25% down | 10% down | ||
| 151 | Twist BioscienceTWST · Health Care | SGD 217.8M | SGD 10.2B | SGD 150.03 | 3.88% up | 346% up | ||
| 152 | Kymera TherapeuticsKYMR · Health Care | SGD 210.4M | SGD 13.3B | SGD 156.19 | 0.32% down | 87% up | ||
| 153 | Scholar Rock HoldingSRRK · Health Care | SGD 204.7M | SGD 7.6B | SGD 61.89 | 6.48% up | 26% up | ||
| 154 | BillionToOneBLLN · Health Care | SGD 196.7M | SGD 5.6B | SGD 118.04 | 6.11% down | 4% down | ||
| 155 | ABIVAXABVX · Health Care | SGD 184.7M | SGD 9.5B | SGD 108.09 | 2.11% up | 32% down | ||
| 156 | Krystal BiotechKRYS · Health Care | SGD 147.3M | SGD 12B | SGD 406.62 | 5.62% up | 54% up | ||
| 157 | Definium TherapeuticsDFTX · Health Care | SGD 139M | SGD 5.1B | SGD 37.55 | 0.88% down | 168% up | ||
| 158 | ImmunovantIMVT · Health Care | SGD 134.6M | SGD 8.9B | SGD 42.77 | 0.12% down | 46% up | ||
| 159 | Summit TherapeuticsSMMT · Health Care | SGD 119M | SGD 10.8B | SGD 13.54 | 1.59% down | 36% down | ||
| 160 | ErascaERAS · Health Care | SGD 91.5M | SGD 6.2B | SGD 17.74 | 0.94% down | 395% up | ||
| 161 | Spyre TherapeuticsSYRE · Health Care | SGD 80.6M | SGD 12.4B | SGD 130.83 | 8.15% up | 332% up | ||
| 162 | Praxis Precision MedicinesPRAX · Health Care | SGD 77.1M | SGD 11B | SGD 393.53 | 0.04% up | 86% up | ||
| 163 | HeartflowHTFL · Health Care | SGD 75.8M | SGD 5.2B | SGD 59.17 | 2.51% down | 66% up | ||
| 164 | Protagonist TherapeuticsPTGX · Health Care | SGD 69M | SGD 10.7B | SGD 163.97 | 2.00% up | 51% up | ||
| 165 | CG OncologyCGON · Health Care | SGD 50.3M | SGD 9.2B | SGD 103.16 | 1.34% up | 97% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | SGD 48.4M | SGD 6.1B | SGD 108.29 | 3.45% down | 108% up | ||
| 167 | Edgewise TherapeuticsEWTX · Health Care | SGD 39.1M | SGD 5.8B | SGD 53.34 | 1.59% down | 86% up | ||
| 168 | Oruka TherapeuticsORKA · Health Care | SGD 21.5M | SGD 8.4B | SGD 123.45 | 0.60% down | 255% up | ||
| 169 | Belite BioBLTE · Health Care | SGD 13M | SGD 8.2B | SGD 201.45 | 0.94% down | 43% up | ||
| 170 | VeradermicsMANE · Health Care | SGD 11.8M | SGD 6.8B | SGD 161.00 | 0.62% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2894 SGD).
Questions and answers
Which health care companies rank first by total liabilities?
UnitedHealth Group (SGD 268.1B), CVS Health (SGD 229.7B) and AbbVie (SGD 176.9B) are the top three of the 170 health care companies ranked by total liabilities as of 19 Nov 2026, 14:03 UTC.
How many health care companies are in this ranking?
170 are ranked by total liabilities.
What are these health care companies worth together?
The 170 health care companies ranked by total liabilities have a combined market value of SGD 11.73T as of 19 Nov 2026, 14:03 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.